Upgrade to SI Premium - Free Trial

Alkermes (ALKS) PT Raised to $38 at TD Cowen

February 13, 2025 8:36 AM
TD Cowen analyst Joseph Thome raised the price target on Alkermes (NASDAQ: ALKS) to $38.00 (from $35.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles